Oscar Health is trading at $35.45 (17.7% up) in pre-market trading as investors position ahead of its Q2 2026 earnings release scheduled for August 06, 2026.
- Market expectations for the upcoming report include revenue of $4.93 billion and earnings per share (EPS) of $0.43.
- Investors are closely monitoring the company’s Medical Loss Ratio (MLR) trajectory, which has been a primary focus in recent analyst previews.